Showing results (341-350 of 1,150) with videos related to

Sort By:
Pageof 115
Hematology. American Society of Hematology. Education Program|November 28, 2001
Platelets: an update on diagnosis and management of thrombocytopenic disordersK R McCrae, J B Bussel, P M Mannucci, et al.
Thrombosis and Haemostasis|January 4, 1998
Free protein S deficiency is a risk factor for venous thrombosisE M Faioni, C Valsecchi, A Palla, et al.
Thrombosis and Haemostasis|March 2, 1992
Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrateP M Mannucci, A Gringeri, R de Biasi, et al.
International Journal of Clinical & Laboratory Research|January 1, 1992
Carrier detection and prenatal diagnosis of hemophilia A: 5-years experience at a hemophilia centerE Sacchi, A M Randi, L Tagliavacca, et al.
European Journal of Haematology|February 1, 1988
Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factorF Rodeghiero, G Castaman, E Di Bona, et al.
Journal of Endocrinological Investigation|May 10, 2000
Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndromeL M Fatti, B Bottasso, C Invitti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2012
Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studiesA Coppola, M Franchini, M Makris, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1976
Studies on the prolonged bleeding time in von Willebrand's diseaseP M Mannucci, F I Pareti, L Holmberg, et al.
Thrombosis and Haemostasis|October 1, 1994
Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patientsE Santagostino, A Gringeri, A Rocino, et al.
Thrombosis Research|June 15, 1991
Effects of subcutaneously administered dermatan sulfate (MF 701) on the coagulation and fibrinolytic parameters of healthy volunteersA Tripodi, M Moia, B Bottasso, et al.
Pageof 115